Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Subscribe To Our Newsletter & Stay Updated
